Bahri Gok

Especialidad: Urólogo
18 años de experiencia
Idiomas:
Turco
Consultas online: disponible
Consultorio: Turquía, Ankara, Lokman Hekim University Ankara Hospital
Investigador en un ensayo clínico internacional de fase 2 de Merck Sharp & Dohme sobre terapia adyuvante con V940 (mRNA-4157) más pembrolizumab para el carcinoma urotelial infiltrante de músculo de alto riesgo.
El Dr. Bahri Gok es urólogo en el Hospital LHÜ de Ankara (2024–). Obtuvo su título de médico en la Universidad de Selçuk (2001–2007). Completó la residencia en Urología en el Hospital de Formación e Investigación Atatürk de Ankara (2008–2013). Se desempeñó en el Departamento de Urología de la Universidad Ankara Yıldırım Beyazıt como profesor asistente (2017–2020) y profesor asociado (2020–2023). Fue supervisor de formación en Urología en el Hospital de la Ciudad de Ankara (2019–2023).

Acreditaciones y formación: entrenamiento como Cirujano de Consola da Vinci en IRCAD (05.11.2019). Asistió a la reunión de la Sección de Urología Robótica de la EAU (2018) y a los Congresos Nacionales de Endourología (2013, 2015, 2019). Completó un curso de bioestadística (2018) y posee un certificado de uso de animales de laboratorio (2012). Membresías: SIU; Asociación Turca de Urología; Sociedad de Cirugía Urológica; Asociación Euroasiática de Uro-oncología.

Logros: investigador en un ensayo internacional de fase 2 en 2024 de V940 (mRNA‑4157) adyuvante más pembrolizumab para carcinoma urotelial músculo‑invasivo de alto riesgo. Dirigió en 2020 una tesis doctoral sobre prostatectomía radical asistida por robot. Recibió premios al Mejor Póster en la EAU (Letonia, 2015) y en las reuniones de Uro‑oncología Euroasiática y de la SIU (2019).

Consulta médica online con Bahri Gok

Cómodo y sencillo

100% segura y confidencial

$100

¿Qué tal su experiencia?

1 de 3

La información sobre este doctor es completa y clara

Totalmente en desacuerdo

Totalmente de acuerdo

Formación académica

EDUCATION INFORMATION

Year – Institution – Department
2001–2007: Selçuk University, Faculty of Medicine
2008–2013: Ankara Atatürk Training and Research Hospital, Urology
2020–Present: Ankara Yıldırım Beyazıt University, Urology

EXPERIENCE INFORMATION

Year – Institution – Department
2007: Sivas Altınyayla State Hospital – General Practitioner

2007: Gazi University, Faculty of Medicine, Department of Radiation Oncology – Research Assistant

2008–2013: Ankara Atatürk Training and Research Hospital – Resident (Urology Specialization)

2013: Şırnak State Hospital – Urology Specialist

2013: Gaziantep 25 Aralık State Hospital – Urology Specialist

2014–2017: Kayseri Training and Research Hospital, Urology Clinic – Urology Specialist

2017–2020: Ankara Yıldırım Beyazıt University, Faculty of Medicine, Department of Urology – Assistant Professor

2020–2023: Ankara Yıldırım Beyazıt University, Faculty of Medicine, Department of Urology – Associate Professor

2019–2023: Ankara City Hospital, Urology Clinic – Training Supervisor

2023–2024: Memorial Ankara Hospital – Associate Professor

2024–Present: LHÜ Ankara Hospital – Urology (Bevliye)

Certificates Received

Online Eurasian Uro-Oncology Congress, Certificate of Attendance (International), 27–28 June 2020

Certificate of da Vinci System Training as a Console Surgeon, IRCAD (International), 05.11.2019

13th National Endourology Congress, Participation Certificate, Antalya (National), 11–14 April 2019

27th National Urology Congress, Participation Certificate, Bafra (National), 26–29 October 2018

Biostatistics Course, Ankara Limak Ambassador Hotel (National), 22.09.2018

15th Meeting of the EAU Robotic Urology Section, Certificate of Attendance, Marseille (International), 05–07 September 2018

Trainer Training Certificate, Sakarya (National), July 2016

11th National Endourology Congress, Participation Certificate, Mardan Palace Hotel (National), 23–26 April 2015

10th National Endourology Congress, Participation Certificate, Maxx Royal Hotel Convention Center (National), 11–14 April 2013

5th Uro-oncology Winter Congress, Certificate of Participation, Macedonian Academy of Sciences and Arts (International), 30 January–03 February 2013

Laboratory Animal Usage Certificate Program, KOBAY Laboratory (National), 01–14 May 2012

22nd National Urology Congress, Participation Certificate, Acapulco Resort Hotel (National), 02–06 May 2012

21st National Urology Congress, Participation Certificate, Istanbul Lütfi Kırdar Congress Center (National), 30 Oct–03 Nov 2010

Bakırköy Medical Days “New Techniques and Technologies,” Titanic Port Hotel (National), 23–24 April 2010

Supervised Doctoral Theses

Elchin Hajiyev (2020):
Comparison of operative, oncological, and functional parameters of patients under 55 and over 65 with high-risk prostate cancer who underwent robot-assisted laparoscopic radical prostatectomy.
Ankara Yıldırım Beyazıt University → Ankara Bilkent City Hospital → Urology Department (Completed)

Project Roles

Investigator in the international, multicenter clinical research study sponsored by Merck Sharp & Dohme dated May 17, 2024:
A Phase 2, randomized, double-blind, placebo- and active-comparator-controlled study evaluating adjuvant V940 (mRNA-4157) plus pembrolizumab versus placebo plus pembrolizumab in volunteers with high-risk muscle-invasive urothelial carcinoma after radical resection.